Document is current

Article History

Received: 3 May 2020

Accepted: 8 August 2020

First Online: 24 August 2020

Ethics approval and consent to participate

: This trial protocol was approved by the Ethics Committee of the National Center for Child Health and Development (protocol identification No.1721) and the Ethics Committee of the Ministry of Health of the Republic of Angola (protocol identification No. 15/2018).All eligible participants will be briefed on the study details prior to enrolment. Potential study participants will be asked to sign the informed consent form which will be returned to the interviewer. During the consent process, the objective, procedures, risks and benefits of the study will be explained to the participants and she will be encouraged to ask questions for clarifications. They will also be advised that their participation is voluntary and may choose not to participate in or withdraw her participation from the study at any time. Any participant who declines to join the study or who withdraws their participation in the study will be entitled to the same quality of care as study participants and treated without prejudice. Study participants will be given the assurance of anonymity and confidentiality of all collected information, before, during and after the trial. If an ancillary study is conducted, a signed informed consent will be obtained from every participant in the study if data collection/requests are not covered in the original informed consent process for the main Angola Maternal and Child Health Handbook Implementation Research Project.Any protocol modifications will be communicated to the respective committees and the trial sponsors and registered on the ISRCTN.

: Not applicable

: None declared. This document is not a formal publication of JICA, and the views expressed in this document by named authors are solely the responsibility of those authors.